Intracystic Injection of NanoPac® in Subjects With Mucinous Cystic Pancreatic Neoplasms
Status:
Completed
Trial end date:
2020-06-29
Target enrollment:
Participant gender:
Summary
This study will evaluate intracystic NanoPac® (Sterile Nanoparticulate Paclitaxel)
administered via endoscopic ultrasound-guided fine needle injection (EUS-FNI) in subjects
with mucinous cystic pancreatic neoplasms.